Valsartan 160mg Hydrochlorothiazide 12.5mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

valsartan 160mg hydrochlorothiazide 12.5mg tablets

aurobindo pharma ltd - valsartan; hydrochlorothiazide - tablet - 160mg ; 12.5mg

DILART HCT 160/12.5 mg valsartan 160 mg/ hydrochlorothiazide 12.5 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

dilart hct 160/12.5 mg valsartan 160 mg/ hydrochlorothiazide 12.5 mg film-coated tablet blister pack

alphapharm pty ltd - hydrochlorothiazide, quantity: 12.5 mg; valsartan, quantity: 160 mg - tablet, film coated - excipient ingredients: lactose monohydrate; colloidal anhydrous silica; povidone; sodium lauryl sulfate; crospovidone; magnesium stearate; pregelatinised maize starch; microcrystalline cellulose; titanium dioxide; hypromellose; purified talc; iron oxide red; macrogol 400 - dilart?hct is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

Valsartan 160mg Hydrochlorothiazide 12.5mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

valsartan 160mg hydrochlorothiazide 12.5mg tablets

consilient health ltd - valsartan; hydrochlorothiazide - tablet - 160mg ; 12.5mg

Valsartan 160mg Hydrochlorothiazide 12.5mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

valsartan 160mg hydrochlorothiazide 12.5mg tablets

actavis uk ltd - valsartan; hydrochlorothiazide - tablet - 160mg ; 12.5mg

Valsartan/Hydrochlorothiazide KRKA 160 mg - 12.5 mg film-coat. tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

valsartan/hydrochlorothiazide krka 160 mg - 12.5 mg film-coat. tabl.

krka d.d. novo mesto d.d. - hydrochlorothiazide 12,5 mg; valsartan 160 mg - film-coated tablet - 160 mg - 12,5 mg - valsartan 160 mg; hydrochlorothiazide 12.5 mg - valsartan and diuretics

CO-DIOVAN 160/12.5 valsartan 160 mg and hydrochlorothiazide 12.5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

co-diovan 160/12.5 valsartan 160 mg and hydrochlorothiazide 12.5 mg tablet blister pack

novartis pharmaceuticals australia pty ltd - hydrochlorothiazide, quantity: 12.5 mg; valsartan, quantity: 160 mg - tablet, film coated - excipient ingredients: crospovidone; microcrystalline cellulose; titanium dioxide; purified talc; iron oxide red; macrogol 8000; magnesium stearate; hypromellose; colloidal anhydrous silica - co-diovan is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

Valsartan and Hydrochlorothiazide 160mg/12.5mg film-coated Tablets Malta - English - Medicines Authority

valsartan and hydrochlorothiazide 160mg/12.5mg film-coated tablets

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - hydrochlorothiazide, valsartan - film-coated tablet - hydrochlorothiazide 160 mg valsartan 12.5 mg - agents acting on the renin-angiotensin system

AMLODIPINE/VALSARTAN/HCT NOVARTIS 5/160/12.5 amlodipine/valsartan/hydrochlorothiazide tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

amlodipine/valsartan/hct novartis 5/160/12.5 amlodipine/valsartan/hydrochlorothiazide tablet blister pack

novartis pharmaceuticals australia pty ltd - valsartan, quantity: 160 mg; hydrochlorothiazide, quantity: 12.5 mg; amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg) - tablet, film coated - excipient ingredients: crospovidone; microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; titanium dioxide; hypromellose; purified talc; macrogol 4000 - amlodipine/valsartan/hct novartis is indicated only as substitution therapy for the treatment of hypertension in patients whose blood pressure is already adequately controlled on the triple combination of amlodipine, valsartan and hydrochlorothiazide taken either as three single component formulations or as dual-component formulation with a single component formulation, all components at the same dose level. treatment should not be initiated with these fixed-dose combinations (see dosage and administration).

Exforge HCT 10/160/12.5 12.5 mg, 160 mg, 10 mg Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

exforge hct 10/160/12.5 12.5 mg, 160 mg, 10 mg

شركة مستودع الأدوية الأردني - the jordan drugstore co - hydrochlorothiazide 12.5 mg, valsartan 160 mg, amlodipine 10 mg - 12.5 mg, 160 mg, 10 mg

DILART HCT 160/12.5 mg valsartan 160 mg/hydrochlorothiazide 12.5 mg film-coated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

dilart hct 160/12.5 mg valsartan 160 mg/hydrochlorothiazide 12.5 mg film-coated tablet bottle

alphapharm pty ltd - hydrochlorothiazide,valsartan -